LENZ THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
LENZ THERAPEUTICS, INC. (LENZ) had Common Stock, Capital Shares Reserved for Future Issuance of 6.41 million shares as of 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-24
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 6.41M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 6.47M shares.
- 2025-06-30: Common Stock, Capital Shares Reserved for Future Issuance 6.55M shares.
- 2025-03-31: Common Stock, Capital Shares Reserved for Future Issuance 6.59M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 6.41M shares 10-K · filed 2026-03-24 |
| 2025-09-30 | 6.47M shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 6.55M shares 10-Q · filed 2025-07-30 |
| 2025-03-31 | 6.59M shares 10-Q · filed 2025-05-07 |
| 2024-12-31 | 4.95M shares 10-K · filed 2025-03-19 |
| 2024-09-30 | 4.98M shares 10-Q · filed 2024-11-06 |
| 2023-12-31 | 17.43M shares 10-K · filed 2024-02-27 |
| 2023-09-30 | 17.47M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 17.45M shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 17.40M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 13.89M shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 13.70M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 13.71M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 13.42M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 10.03M shares 10-K · filed 2023-03-20 |
| 2021-09-30 | 10.28M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 10.57M shares 10-Q · filed 2021-08-12 |
| 2020-12-31 | 14.71M shares 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |